Top Story

FDA approves Obizur for acquired hemophilia A

October 24, 2014

The FDA approved Obizur for the treatment of bleeding disorders in adults with acquired hemophilia A.

The development of acquired hemophilia A — a non-genetic Factor VIII deficiency — has been associated with pregnancy, cancer and the use of certain medications, but about half of cases originate from unknown causes.

In the Journals

Efficacy of VTE chemoprophylaxis in otolaryngology patients varied by subgroup

October 24, 2014
The efficacy and safety of venous thromboembolism chemoprophylaxis for individuals undergoing otolaryngologic surgery varied based on Caprini risk score and the type of…
figure Meeting News Coverage

ACG president addresses improved prevention, detection, treatment in IBD cancers

October 24, 2014
PHILADELPHIA — At the ACG Annual Scientific Meeting, the incoming president of the college covered cancer in the setting of ulcerative colitis, including…
In the Journals

Recombinant Factor VIII product increased inhibitor development risk

October 24, 2014
One recombinant Factor VIII product was associated with an increased risk for inhibitor formation compared with similar products for the treatment of severe hemophilia…
More News Headlines »
Health Care Legislative and Regulatory Update
figure

The Sunshine Act and CME-related payments

Spine Surgery Today, September/October 2014
Abraham Gitterman; Marilyn May, JD
From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and…
More »
Meeting News Coverage Video
figure

Nomogram predicted recurrence risk among women who underwent APBI

September 26, 2014
Jessica Wobb, MD, senior resident in radiation oncology at Beaumont Health System in Birmingham, Mich., describes how…
More »